产前补充胆钙化醇的反应与常见维生素D相关基因变异相关
该研究基于母婴维生素D骨质疏松试验的随机化组内分析,纳入682名白人孕妇(安慰剂351例、胆钙化醇331例),探讨DHCR7、CYP2R1、CYP24A1和GC基因单核苷酸多态性与产前补充胆钙化醇后25(OH)D水平的关系。结果显示,rs12785878(DHCR7)与基线25(OH)D相关,而rs10741657(CYP2R1)和rs2282679(GC)与补充后达到的25(OH)D状态相关。
要点
- rs12785878(DHCR7)与基线25(OH)D相关(β=3.1 nmol/L)。
- rs10741657(CYP2R1)与补充后25(OH)D相关(β=-5.2 nmol/L)。
- rs2282679(GC)与补充后25(OH)D相关(β=4.2 nmol/L)。
核心结论
- DHCR7基因变异似乎修饰基线25(OH)D,而对产前胆钙化醇补充的反应与CYP2R1和GC的单核苷酸多态性相关。
研究设计与样本
- 母婴维生素D骨质疏松试验的随机化组内分析,共纳入682名白人孕妇(安慰剂351例、胆钙化醇331例)。
- 干预为自妊娠14周至分娩每日1000 IU胆钙化醇。
- 对rs12785878(DHCR7)、rs10741657(CYP2R1)、rs6013897(CYP24A1)和rs2282679(GC)进行基因分型。
- 采用加性模型线性回归评估25(OH)D与单核苷酸多态性的关联,β表示每增加一个常见等位基因的25(OH)D变化。
主要发现
- 仅rs12785878(DHCR7)与基线25(OH)D相关(β=3.1 nmol/L;95%CI 1.0至5.2 nmol/L;P<0.004)。
- rs10741657(CYP2R1)与补充后达到的25(OH)D状态相关(β=-5.2 nmol/L;95%CI -8.2至-2.2 nmol/L;P=0.001)。
- rs2282679(GC)与补充后达到的25(OH)D状态相关(β=4.2 nmol/L;95%CI 0.9至7.5 nmol/L;P=0.01)。
- rs12785878和rs6013897(CYP24A1)与补充后达到的25(OH)D状态不相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Single-nucleotide polymorphisms (SNPs) in genes related to vitamin D metabolism have been associated with serum 25-hydroxyvitamin D [25(OH)D] concentration, but these relationships have not been examined following antenatal cholecalciferol supplementation. OBJECTIVE: To determine whether SNPs in DHCR7, CYP2R1, CYP24A1, and GC are associated with the response to gestational cholecalciferol supplementation. DESIGN: Within-randomization group analysis of the Maternal Vitamin D Osteoporosis Study trial of antenatal cholecalciferol supplementation. SETTING: Hospital antenatal clinics. PARTICIPANTS: In total, 682 women of white ethnicity (351 placebo, 331 cholecalciferol) were included. SNPs at rs12785878 (DHCR7), rs10741657 (CYP2R1), rs6013897 (CYP24A1), and rs2282679 (GC) were genotyped. INTERVENTIONS: 1000 IU/d cholecalciferol from 14 weeks of gestation until delivery. MAIN OUTCOME MEASURE: 25(OH)D at randomization and 34 weeks of gestation were measured in a single batch (Liaison; Diasorin, Dartford, UK). Associations between 25(OH)D and the SNPs were assessed by linear regression using an additive model [β represents the change in 25(OH)D per additional common allele]. RESULTS: Only rs12785878 (DHCR7) was associated with baseline 25(OH)D [β = 3.1 nmol/L; 95% confidence interval (CI), 1.0 to 5.2 nmol/L; P < 0.004]. In contrast, rs10741657 (CYP2R1) (β = -5.2 nmol/L; 95% CI, -8.2 to -2.2 nmol/L; P = 0.001) and rs2282679 (GC) (β = 4.2 nmol/L; 95% CI, 0.9 to 7.5 nmol/L; P = 0.01) were associated with achieved 25(OH)D status following supplementation, whereas rs12785878 and rs6013897 (CYP24A1) were not. CONCLUSIONS: Genetic variation in DHCR7, which encodes 7-dehyrocholesterol reductase in the epidermal vitamin D biosynthesis pathway, appears to modify baseline 25(OH)D. In contrast, the response to antenatal cholecalciferol supplementation was associated with SNPs in CYP2R1, which may alter 25-hydroxylase activity, and GC, which may affect vitamin D binding protein synthesis or metabolite affinity.
引用
- Moon RJ, Harvey NC, Cooper C, et al. Response to Antenatal Cholecalciferol Supplementation Is Associated With Common Vitamin D-Related Genetic Variants. J Clin Endocrinol Metab. 2017. PMID: 28575224. doi:10.1210/jc.2017-00682
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。